Pub Date : 2025-08-05DOI: 10.22365/jpsych.2025.013
Garifalia Bitzi, Ioulia Kokka, Iraklis Mourikis
Vulvodynia is an underdiagnosed pain syndrome with persistent duration, usually without an identifiable organic cause. It negatively affects the quality of life, mental health and romantic relationships and sexual function of women. This review aimed to systematically appraise the available data on the effectiveness of Cognitive Behavioral Therapy on perceived pain and sexual functioning of women with vulvodynia from randomized clinical trials irrespective of their time of publication. The review was performed following the PRISMA guidelines. The literature search was conducted based on specific eligibility criteria in the PubMed, PsycInfo, and Scopus databases using appropriate keywords. The methodological quality of the included studies was assessed with the Jadad Scale. The search resulted in 10 randomized clinical trials that compared the effectiveness of Cognitive Behavioral Therapy compared to other psychotherapeutic approaches and clinical, pharmaceutical, and surgical interventions on 835 women with vulvodynia. The results, which were synthesized narratively based on intervention type and outcomes assessed, revealed the superiority of Cognitive Behavioral Therapy compared to topical treatments with significant improvements in sexual function and pain management, particularly evident at follow-up assessments. Comparisons with other psychotherapeutic approaches (mindfulness-based cognitive therapy, supportive psychotherapy) resulted in similar results. Compared to physiotherapeutic and surgical protocols, Cognitive Behavioral Therapy resulted in more favorable findings, although the improvement regarding sexual function was significant mostly at the 6-month follow-up measurements. Cognitive Behavioral Therapy appeared to help by restructuring dysfunctional beliefs, reducing pain catastrophizing, and developing alternative pain coping strategies. Despite the encouraging evidence, variations with respect to the cognitive-behavioral interventions, comparison groups, and assessment tools used to assess the variables under investigation, direct comparison of the findings was challenging. The results highlighted Cognitive Behavioral Therapy as a promising, non-pharmacological approach to the management of vulvodynia. Education of psychotherapists and clinicians, particularly gynecologists, would contribute to early diagnosis and effective treatment of vulvodynia.
{"title":"A systematic review on the efficacy of CBT on pain and sexual function of vulvodynia.","authors":"Garifalia Bitzi, Ioulia Kokka, Iraklis Mourikis","doi":"10.22365/jpsych.2025.013","DOIUrl":"https://doi.org/10.22365/jpsych.2025.013","url":null,"abstract":"<p><p>Vulvodynia is an underdiagnosed pain syndrome with persistent duration, usually without an identifiable organic cause. It negatively affects the quality of life, mental health and romantic relationships and sexual function of women. This review aimed to systematically appraise the available data on the effectiveness of Cognitive Behavioral Therapy on perceived pain and sexual functioning of women with vulvodynia from randomized clinical trials irrespective of their time of publication. The review was performed following the PRISMA guidelines. The literature search was conducted based on specific eligibility criteria in the PubMed, PsycInfo, and Scopus databases using appropriate keywords. The methodological quality of the included studies was assessed with the Jadad Scale. The search resulted in 10 randomized clinical trials that compared the effectiveness of Cognitive Behavioral Therapy compared to other psychotherapeutic approaches and clinical, pharmaceutical, and surgical interventions on 835 women with vulvodynia. The results, which were synthesized narratively based on intervention type and outcomes assessed, revealed the superiority of Cognitive Behavioral Therapy compared to topical treatments with significant improvements in sexual function and pain management, particularly evident at follow-up assessments. Comparisons with other psychotherapeutic approaches (mindfulness-based cognitive therapy, supportive psychotherapy) resulted in similar results. Compared to physiotherapeutic and surgical protocols, Cognitive Behavioral Therapy resulted in more favorable findings, although the improvement regarding sexual function was significant mostly at the 6-month follow-up measurements. Cognitive Behavioral Therapy appeared to help by restructuring dysfunctional beliefs, reducing pain catastrophizing, and developing alternative pain coping strategies. Despite the encouraging evidence, variations with respect to the cognitive-behavioral interventions, comparison groups, and assessment tools used to assess the variables under investigation, direct comparison of the findings was challenging. The results highlighted Cognitive Behavioral Therapy as a promising, non-pharmacological approach to the management of vulvodynia. Education of psychotherapists and clinicians, particularly gynecologists, would contribute to early diagnosis and effective treatment of vulvodynia.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144822307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-05DOI: 10.22365/jpsych.2025.019
Tatyana Vasiliyevna Polukchi
Depression is a common issue among patients with chronic viral hepatitis. Living with chronic hepatitis can create chronic stress, which is a known risk factor for developing or exacerbating depression. This stress can be related to concerns about health, the effectiveness of treatment, and the social implications of the illness. Neuropsychological scales and assessments can objectively measure the severity of depression and other mental health issues in these patients. The presence of depression was studied in 233 patients with chronic viral hepatitis, who were treated in the Infectious Disease Hospital of Shymkent and the Regional Hepatology Centre of Shymkent in the period from March 2021 to January 2022. All patients were examined using the Hamilton Depression Rating Scale (HDRS) to identify the presence of depression. Of the 233 patients with chronic viral hepatitis, 38.3% had mild depressive disorder, 2.7% of patients had scores indicating moderate depressive disorder, and 2.7% of patients were found to have major depressive disorder. Multivariate analysis showed that older age, the form of chronic viral hepatitis, higher viral load, and female gender were most strongly associated with depression. Depression is a common manifestation in patients with chronic viral hepatitis and can lead to cognitive impairments such as difficulties with concentration, memory problems, and decreased executive function. In the context of chronic hepatitis, which may already affect liver function and metabolic processes, untreated depression can exacerbate these cognitive deficits.
{"title":"Prevalence and severity of depression in patients with chronic viral hepatitis in Kazakhstan.","authors":"Tatyana Vasiliyevna Polukchi","doi":"10.22365/jpsych.2025.019","DOIUrl":"https://doi.org/10.22365/jpsych.2025.019","url":null,"abstract":"<p><p>Depression is a common issue among patients with chronic viral hepatitis. Living with chronic hepatitis can create chronic stress, which is a known risk factor for developing or exacerbating depression. This stress can be related to concerns about health, the effectiveness of treatment, and the social implications of the illness. Neuropsychological scales and assessments can objectively measure the severity of depression and other mental health issues in these patients. The presence of depression was studied in 233 patients with chronic viral hepatitis, who were treated in the Infectious Disease Hospital of Shymkent and the Regional Hepatology Centre of Shymkent in the period from March 2021 to January 2022. All patients were examined using the Hamilton Depression Rating Scale (HDRS) to identify the presence of depression. Of the 233 patients with chronic viral hepatitis, 38.3% had mild depressive disorder, 2.7% of patients had scores indicating moderate depressive disorder, and 2.7% of patients were found to have major depressive disorder. Multivariate analysis showed that older age, the form of chronic viral hepatitis, higher viral load, and female gender were most strongly associated with depression. Depression is a common manifestation in patients with chronic viral hepatitis and can lead to cognitive impairments such as difficulties with concentration, memory problems, and decreased executive function. In the context of chronic hepatitis, which may already affect liver function and metabolic processes, untreated depression can exacerbate these cognitive deficits.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144822346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Electroconvulsive therapy (ECT) remains one of the most effective treatments for patients with treatment-resistant major depressive disorder (TR-MDD). However, the biological mechanisms underlying its therapeutic effects are not yet fully understood. Epigenetic regulation has recently emerged as a promising field for elucidating the molecular underpinnings of ECT response. This systematic review aimed to identify and synthesize existing studies investigating epigenetic biomarkers associated with ECT outcomes in human populations. A systematic review was conducted in PubMed and Scopus for studies published between January 2015 and March 2025. The review adhered to PRISMA 2020 guidelines. Inclusion criteria were: (1) original, peer-reviewed studies; (2) investigation of ECT-induced effects on epigenetic markers; and (3) diagnosis of major depressive disorder. Extracted data included epigenetic targets, patient characteristics, ECT parameters, and clinical outcomes. Risk of bias and heterogeneity were taken into account in the synthesis. Eleven studies met the inclusion criteria, encompassing a total of 498 patients with TR-MDD. Across studies, 31 promising epigenetic biomarkers were identified, including genes involved in neuroplasticity, hypothalamic-pituitary-adrenal (HPA) axis regulation, inflammation, immune signaling, and non-coding RNAs. DNA methylation and microRNA (miRNA) expression were the most frequently studied mechanisms. No studies to date have investigated histone modifications in human subjects undergoing ECT. This systematic review provides preliminary evidence that epigenetic mechanisms-particularly DNA methylation and miRNA expression-may play a role in modulating response to ECT in patients with TR-MDD. While these findings offer important insights for clinical stratification and precision psychiatry, they are limited by small sample sizes and methodological variability. Larger, standardized, and longitudinal studies are needed to validate these initial findings and support translational applications.
{"title":"Towards Precision ECT: A systematic review of epigenetic biomarkers in treatment-resistant depression.","authors":"Nikolaos Statharakos, Vasilios Savvidis, Taxiarchis Gravanis","doi":"10.22365/jpsych.2025.021","DOIUrl":"https://doi.org/10.22365/jpsych.2025.021","url":null,"abstract":"<p><p>Electroconvulsive therapy (ECT) remains one of the most effective treatments for patients with treatment-resistant major depressive disorder (TR-MDD). However, the biological mechanisms underlying its therapeutic effects are not yet fully understood. Epigenetic regulation has recently emerged as a promising field for elucidating the molecular underpinnings of ECT response. This systematic review aimed to identify and synthesize existing studies investigating epigenetic biomarkers associated with ECT outcomes in human populations. A systematic review was conducted in PubMed and Scopus for studies published between January 2015 and March 2025. The review adhered to PRISMA 2020 guidelines. Inclusion criteria were: (1) original, peer-reviewed studies; (2) investigation of ECT-induced effects on epigenetic markers; and (3) diagnosis of major depressive disorder. Extracted data included epigenetic targets, patient characteristics, ECT parameters, and clinical outcomes. Risk of bias and heterogeneity were taken into account in the synthesis. Eleven studies met the inclusion criteria, encompassing a total of 498 patients with TR-MDD. Across studies, 31 promising epigenetic biomarkers were identified, including genes involved in neuroplasticity, hypothalamic-pituitary-adrenal (HPA) axis regulation, inflammation, immune signaling, and non-coding RNAs. DNA methylation and microRNA (miRNA) expression were the most frequently studied mechanisms. No studies to date have investigated histone modifications in human subjects undergoing ECT. This systematic review provides preliminary evidence that epigenetic mechanisms-particularly DNA methylation and miRNA expression-may play a role in modulating response to ECT in patients with TR-MDD. While these findings offer important insights for clinical stratification and precision psychiatry, they are limited by small sample sizes and methodological variability. Larger, standardized, and longitudinal studies are needed to validate these initial findings and support translational applications.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144822377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-05DOI: 10.22365/jpsych.2025.015
Niha Fathima Imthiaz, Spandana P Hegde, Shashwath Sathyanath, Manjunath M Shenoy, Malcolm Pinto, Ashmiya Razak
Chronic dermatophytosis, a persistent fungal infection lasting over six months, is a significant public health concern. The study examines the psychosocial well-being, psychological distress, and financial burden experienced by patients with chronic and recurrent dermatophytosis. A hospital-based cross-sectional design was employed, enrolling 316 patients from a tertiary care dermatology outpatient department in South India over six months. Participants completed questionnaires of quality of life (Dermatology Life Quality Index, DLQI), financial burden (Financial Burden and Worry questionnaire, FBW), and psychological distress (Hospital Anxiety and Depression Scale, HADS). Findings revealed a substantial impact on the quality of life, with 71.6% of participants reporting a very large effect as per DLQI scores. Factors such as itching, embarrassment, and daily routine disturbances were significantly associated with higher DLQI scores. Financial challenges were prominent, with 56.6% of participants delaying treatment due to financial constraints and 30.7% reducing overall expenses. The economic burden was further evident as 26.2% used savings, 12.9% borrowed money, and 16.1% reduced essential healthcare spending for other family members. Psychological distress was significant, with 31.6% and 29.7% of participants showing abnormal anxiety and depression scores, respectively, on HADS. A strong positive correlation was observed between DLQI scores, anxiety, and depression, highlighting the interdependence between disease severity and mental health. This study underscores the need for a holistic approach to managing chronic dermatophytosis, addressing not only medical but also psychosocial and financial aspects. Integrating affordable treatment options, public health awareness campaigns, and psychological counselling can significantly alleviate the burden on affected individuals. These findings provide critical insights for clinicians and policymakers to design comprehensive care strategies aimed at improving patient outcomes and quality of life.
慢性皮肤真菌病是一种持续6个月以上的持续性真菌感染,是一个重大的公共卫生问题。该研究考察了慢性和复发性皮肤癣患者所经历的社会心理健康、心理困扰和经济负担。采用以医院为基础的横断面设计,在6个月的时间里,从南印度一家三级皮肤科门诊部门招募了316名患者。参与者完成生活质量问卷(Dermatology life quality Index, DLQI)、经济负担问卷(financial burden and Worry questionnaire, FBW)和心理困扰问卷(Hospital Anxiety and Depression Scale, HADS)。研究结果揭示了对生活质量的重大影响,71.6%的参与者报告了DLQI分数的非常大的影响。诸如瘙痒、尴尬和日常干扰等因素与DLQI评分较高显著相关。经济困难突出,56.6%的参与者因经济拮据而推迟治疗,30.7%的参与者减少了总体费用。经济负担进一步明显,26.2%的人使用储蓄,12.9%的人借钱,16.1%的人减少了其他家庭成员的基本医疗保健支出。心理困扰是显著的,31.6%和29.7%的参与者在HADS上分别表现出异常的焦虑和抑郁得分。DLQI评分、焦虑和抑郁之间存在强烈的正相关,强调了疾病严重程度与心理健康之间的相互依存关系。这项研究强调需要一个整体的方法来管理慢性皮肤癣,不仅解决医疗,而且社会心理和财务方面。将负担得起的治疗方案、公共卫生宣传运动和心理咨询结合起来,可大大减轻受影响个人的负担。这些发现为临床医生和政策制定者设计旨在改善患者预后和生活质量的综合护理策略提供了重要见解。
{"title":"Assessment of psychosocial well-being, psychological distress, and financial burden in patients with chronic and recurrent dermatophytosis.","authors":"Niha Fathima Imthiaz, Spandana P Hegde, Shashwath Sathyanath, Manjunath M Shenoy, Malcolm Pinto, Ashmiya Razak","doi":"10.22365/jpsych.2025.015","DOIUrl":"https://doi.org/10.22365/jpsych.2025.015","url":null,"abstract":"<p><p>Chronic dermatophytosis, a persistent fungal infection lasting over six months, is a significant public health concern. The study examines the psychosocial well-being, psychological distress, and financial burden experienced by patients with chronic and recurrent dermatophytosis. A hospital-based cross-sectional design was employed, enrolling 316 patients from a tertiary care dermatology outpatient department in South India over six months. Participants completed questionnaires of quality of life (Dermatology Life Quality Index, DLQI), financial burden (Financial Burden and Worry questionnaire, FBW), and psychological distress (Hospital Anxiety and Depression Scale, HADS). Findings revealed a substantial impact on the quality of life, with 71.6% of participants reporting a very large effect as per DLQI scores. Factors such as itching, embarrassment, and daily routine disturbances were significantly associated with higher DLQI scores. Financial challenges were prominent, with 56.6% of participants delaying treatment due to financial constraints and 30.7% reducing overall expenses. The economic burden was further evident as 26.2% used savings, 12.9% borrowed money, and 16.1% reduced essential healthcare spending for other family members. Psychological distress was significant, with 31.6% and 29.7% of participants showing abnormal anxiety and depression scores, respectively, on HADS. A strong positive correlation was observed between DLQI scores, anxiety, and depression, highlighting the interdependence between disease severity and mental health. This study underscores the need for a holistic approach to managing chronic dermatophytosis, addressing not only medical but also psychosocial and financial aspects. Integrating affordable treatment options, public health awareness campaigns, and psychological counselling can significantly alleviate the burden on affected individuals. These findings provide critical insights for clinicians and policymakers to design comprehensive care strategies aimed at improving patient outcomes and quality of life.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144822343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><p>Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily characterized by cognitive decline. However, there is growing recognition of the significant impact of motor dysfunction in individuals affected by AD. These motor impairments contribute substantially to functional decline, reduced quality of life, and increased caregiver burden in AD patients.1 Current research efforts are increasingly focused on identifying motor dysfunction as a potential early marker in the progression of AD. The temporal relationship between motor and cognitive decline is under intense investigation, with studies suggesting that subtle motor changes, such as gait and balance disturbances or slowed walking speed, may precede detectable cognitive impairment by several years.2 Specifically, research indicates that gait speed predicts a decline in processing speed and visuospatial abilities, and in ApoE4 carriers, it also predicts a memory decline.3 One study found that increased amyloid-beta (Aβ) deposition is associated with reduced gait speed, muscle strength, and balance in cognitively impaired older adults.4 Emerging evidence strongly supports the inclusion of motor function assessments, particularly gait analysis, in the early detection and risk stratification of AD. This could enable earlier interventions and potentially lead to improved disease management. Technological advancements provide increasingly sophisticated non-invasive methods for detecting motor impairments in AD, potentially enabling earlier and more accurate diagnoses. Digital tools and applications-including smartphone-based assessments and virtual reality platforms-are being explored for objective and quantitative evaluation of mobility. These digital measures offer the potential for longitudinal data collection and the detection of subtle changes in motor function over time.5 Digital biomarkers provide the advantage of frequent, objective monitoring in real-world settings, potentially capturing early motor changes that may be missed by traditional clinical evaluations.6 Nonetheless, challenges remain regarding validation, standardization, and the influence of variables such as demographics and disease stage. Wearable devices offer the potential for continuous, non-invasive monitoring of motor behavior, revealing subtle changes indicative of early AD. However, interpreting data from these devices requires careful consideration and further validation in larger studies. Additionally, recent applications of MRI, PET, and other neuroimaging techniques are being examined to detect brain changes related to motor dysfunction in AD. Advanced MRI techniques, such as diffusion tensor imaging (DTI), are used to assess white matter integrity along motor pathways, while molecular PET imaging can visualize amyloid and tau pathology in brain regions associated with motor control.7 Of note, tau pathology in higher motor regions has been significantly associated with cognitive decline. Ad
{"title":"Recent advances in the detection and management of motor dysfunction in Alzheimer's disease.","authors":"Chrysa Marogianni, Vasileios Siokas, Efthimios Dardiotis","doi":"10.22365/jpsych.2025.012","DOIUrl":"10.22365/jpsych.2025.012","url":null,"abstract":"<p><p>Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily characterized by cognitive decline. However, there is growing recognition of the significant impact of motor dysfunction in individuals affected by AD. These motor impairments contribute substantially to functional decline, reduced quality of life, and increased caregiver burden in AD patients.1 Current research efforts are increasingly focused on identifying motor dysfunction as a potential early marker in the progression of AD. The temporal relationship between motor and cognitive decline is under intense investigation, with studies suggesting that subtle motor changes, such as gait and balance disturbances or slowed walking speed, may precede detectable cognitive impairment by several years.2 Specifically, research indicates that gait speed predicts a decline in processing speed and visuospatial abilities, and in ApoE4 carriers, it also predicts a memory decline.3 One study found that increased amyloid-beta (Aβ) deposition is associated with reduced gait speed, muscle strength, and balance in cognitively impaired older adults.4 Emerging evidence strongly supports the inclusion of motor function assessments, particularly gait analysis, in the early detection and risk stratification of AD. This could enable earlier interventions and potentially lead to improved disease management. Technological advancements provide increasingly sophisticated non-invasive methods for detecting motor impairments in AD, potentially enabling earlier and more accurate diagnoses. Digital tools and applications-including smartphone-based assessments and virtual reality platforms-are being explored for objective and quantitative evaluation of mobility. These digital measures offer the potential for longitudinal data collection and the detection of subtle changes in motor function over time.5 Digital biomarkers provide the advantage of frequent, objective monitoring in real-world settings, potentially capturing early motor changes that may be missed by traditional clinical evaluations.6 Nonetheless, challenges remain regarding validation, standardization, and the influence of variables such as demographics and disease stage. Wearable devices offer the potential for continuous, non-invasive monitoring of motor behavior, revealing subtle changes indicative of early AD. However, interpreting data from these devices requires careful consideration and further validation in larger studies. Additionally, recent applications of MRI, PET, and other neuroimaging techniques are being examined to detect brain changes related to motor dysfunction in AD. Advanced MRI techniques, such as diffusion tensor imaging (DTI), are used to assess white matter integrity along motor pathways, while molecular PET imaging can visualize amyloid and tau pathology in brain regions associated with motor control.7 Of note, tau pathology in higher motor regions has been significantly associated with cognitive decline. Ad","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":"97-100"},"PeriodicalIF":0.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144120689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hypnosis is an externally induced alteration in consciousness as a result of suggestion. Hypnotherapy, also called clinical hypnosis, is the use of hypnosis as psychological treatment, either brief or long-term psychotherapy, for alleviating pain, inducing habit modification, and treating a range of physical and mental health problems, such as psychosomatic diseases, mood and anxiety disorders, and personality or behavior disorders. In the present article, the method for therapeutic hypnosis is presented, mainly based on the first author's experience. The method involves muscle relaxation, suggestion, and sensory deprivation, which lead the hypnotized individual to become detached from the environment, allowing them to establish a connection ("rapport"), meaning they have direct contact only with the hypnologist and receive instructions without any external influences. The method used by the first author is that of "rapid" induction of catalepsy, which starts with instructions to remain still with closed eyes. The hypnologist then takes hold of the person's limbs and moves them, stimulating the kinesthetic system responsible for the proprioceptive sense of position in space, thus leading to entering the hypnotic state. Personal characteristics that are associated with the degree of hypnotizability are also presented, as well as the levels of hypnotic state depth, potential complications of hypnosis, and its contraindications, which mainly include psychosis, especially schizophrenia with delusions of influence, and the presence of prominent histrionic personality characteristics. Use of alcohol or illegal substances is not a contraindication; it is, however, noted that, in their presence, the therapeutic effect of hypnosis is uncertain in the absence of other appropriate measures and suitable therapeutic interventions. The effects of hypnosis on the electroencephalogram (EEG) are indicative that the hypnotic state is distinct both from sleep and from full wakefulness. During hypnotic catalepsy, the EEG is characterized (compared to baseline) by an increase in delta rhythm power and an increase in the amplitude and index of theta rhythm, mainly in the temporal leads of both hemispheres. Additionally, there is significant asymmetry between the right and left hemispheres. It must be noted that hypnosis is just the tool through which hypnotherapy is applied. The latter should be only performed by clinicians, psychiatrists, or psychologists trained in psychotherapy, ensuring, thus, the therapeutic value of advice that is given to patients during the period of hypnotic suggestion.
{"title":"[Hypnosis: An ancient therapeutic practice revived in modern science].","authors":"Dimitrios Sakellion, Shokhrukh Sultanov, Dilmurad Irgashev, Ulugbeg Alimov, Vagioula Tsoutsi, Dimitris Dikeos","doi":"10.22365/jpsych.2025.006","DOIUrl":"10.22365/jpsych.2025.006","url":null,"abstract":"<p><p>Hypnosis is an externally induced alteration in consciousness as a result of suggestion. Hypnotherapy, also called clinical hypnosis, is the use of hypnosis as psychological treatment, either brief or long-term psychotherapy, for alleviating pain, inducing habit modification, and treating a range of physical and mental health problems, such as psychosomatic diseases, mood and anxiety disorders, and personality or behavior disorders. In the present article, the method for therapeutic hypnosis is presented, mainly based on the first author's experience. The method involves muscle relaxation, suggestion, and sensory deprivation, which lead the hypnotized individual to become detached from the environment, allowing them to establish a connection (\"rapport\"), meaning they have direct contact only with the hypnologist and receive instructions without any external influences. The method used by the first author is that of \"rapid\" induction of catalepsy, which starts with instructions to remain still with closed eyes. The hypnologist then takes hold of the person's limbs and moves them, stimulating the kinesthetic system responsible for the proprioceptive sense of position in space, thus leading to entering the hypnotic state. Personal characteristics that are associated with the degree of hypnotizability are also presented, as well as the levels of hypnotic state depth, potential complications of hypnosis, and its contraindications, which mainly include psychosis, especially schizophrenia with delusions of influence, and the presence of prominent histrionic personality characteristics. Use of alcohol or illegal substances is not a contraindication; it is, however, noted that, in their presence, the therapeutic effect of hypnosis is uncertain in the absence of other appropriate measures and suitable therapeutic interventions. The effects of hypnosis on the electroencephalogram (EEG) are indicative that the hypnotic state is distinct both from sleep and from full wakefulness. During hypnotic catalepsy, the EEG is characterized (compared to baseline) by an increase in delta rhythm power and an increase in the amplitude and index of theta rhythm, mainly in the temporal leads of both hemispheres. Additionally, there is significant asymmetry between the right and left hemispheres. It must be noted that hypnosis is just the tool through which hypnotherapy is applied. The latter should be only performed by clinicians, psychiatrists, or psychologists trained in psychotherapy, ensuring, thus, the therapeutic value of advice that is given to patients during the period of hypnotic suggestion.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":"149-158"},"PeriodicalIF":0.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143731471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-02Epub Date: 2024-02-27DOI: 10.22365/jpsych.2024.005
Afroditi Stefani, Anna Mavridou, Stelios Chatziioannidis, Vasilios P Bozikas, Agorastos Agorastos
Exposure to childhood trauma experiences shows a high prevalence worldwide, with approximately two-thirds of the general population reporting traumatic experiences during childhood. The valid psychometric assessment of childhood trauma experience represents, however, a significant challenge in clinical research and practice. The Childhood Trauma Questionnaire - Short Form (CTQ-SF) embodies the most valid and internationally widely used tool for the retrospective assessment of traumatic experiences during childhood to date. The purpose of this study was the Greek translation of the questionnaire and its validation in both a general and clinical population. Participants completed electronically the Greek translation of the CTQ-SF, the Early Trauma Questionnaire (ETI-SR-SF), the Trauma Symptom Checklist (TSC-40), the Positive and Negative Affect Scale (PANAS- SF), the Well-Being Index (WHO-5) and the Patient Health Questionnaire (PHQ-4) to examine psychometric properties of the questionnaire (e.g., internal consistency, concurrent, convergent and divergent validity), but also to investigate the relationship between childhood trauma exposure and psychological well-being and symptoms of anxiety and depression. The total study sample (TS) consisted of 722 adults (606 women), of which 155 declared the existence of a psychiatric diagnosis (PD) and 567 constituted the general population (GP) sample. The most common trauma types reported were emotional abuse (29.1%), emotional neglect (23.7%), and physical abuse (24.6%). The CTQ-SF questionnaire showed high levels of internal consistency based on the Cronbach α coefficient (TS = 0.92, PD = 0.92, GP = 0.92), high concurrent and convergent validity and satisfactory convergent validity. In addition, self-reported childhood trauma was highly positively correlated to negative affect and anxiety and depression symptoms, as well as negatively to psychological well-being. Our results confirm that the Greek Version of Childhood Trauma Questionnaire (CTQ-SF) is a reliable and valid tool that can be used for the retrospective assessment of traumatic childhood experiences both in the general and in the clinical adult Greek population.
{"title":"[Childhood Trauma Questionnaire (CTQ): Greek translation and psychometric validation in general and clinical population].","authors":"Afroditi Stefani, Anna Mavridou, Stelios Chatziioannidis, Vasilios P Bozikas, Agorastos Agorastos","doi":"10.22365/jpsych.2024.005","DOIUrl":"10.22365/jpsych.2024.005","url":null,"abstract":"<p><p>Exposure to childhood trauma experiences shows a high prevalence worldwide, with approximately two-thirds of the general population reporting traumatic experiences during childhood. The valid psychometric assessment of childhood trauma experience represents, however, a significant challenge in clinical research and practice. The Childhood Trauma Questionnaire - Short Form (CTQ-SF) embodies the most valid and internationally widely used tool for the retrospective assessment of traumatic experiences during childhood to date. The purpose of this study was the Greek translation of the questionnaire and its validation in both a general and clinical population. Participants completed electronically the Greek translation of the CTQ-SF, the Early Trauma Questionnaire (ETI-SR-SF), the Trauma Symptom Checklist (TSC-40), the Positive and Negative Affect Scale (PANAS- SF), the Well-Being Index (WHO-5) and the Patient Health Questionnaire (PHQ-4) to examine psychometric properties of the questionnaire (e.g., internal consistency, concurrent, convergent and divergent validity), but also to investigate the relationship between childhood trauma exposure and psychological well-being and symptoms of anxiety and depression. The total study sample (TS) consisted of 722 adults (606 women), of which 155 declared the existence of a psychiatric diagnosis (PD) and 567 constituted the general population (GP) sample. The most common trauma types reported were emotional abuse (29.1%), emotional neglect (23.7%), and physical abuse (24.6%). The CTQ-SF questionnaire showed high levels of internal consistency based on the Cronbach α coefficient (TS = 0.92, PD = 0.92, GP = 0.92), high concurrent and convergent validity and satisfactory convergent validity. In addition, self-reported childhood trauma was highly positively correlated to negative affect and anxiety and depression symptoms, as well as negatively to psychological well-being. Our results confirm that the Greek Version of Childhood Trauma Questionnaire (CTQ-SF) is a reliable and valid tool that can be used for the retrospective assessment of traumatic childhood experiences both in the general and in the clinical adult Greek population.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":"110-122"},"PeriodicalIF":0.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140028820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-02Epub Date: 2024-02-27DOI: 10.22365/jpsych.2024.002
Christina Boteli, Stavroula Bargiota, Anna Papakonstantinou, Agorastos Agorastos
The COVID-19 pandemic, which rapidly spread worldwide in early 2020, has affected the daily lives of parents and their children in various ways. This study assessed the overall mental health status and stress experienced by parents during the COVID-19 pandemic and the differences between parents of children with special educational needs and parents of typically developing children. Additionally, we explored potential demographic factors that may influence these experiences. In this cross-sectional study, data were collected through questionnaires completed by a sample of 205 parents (103 of children with typical development attending regular mainstream schools and 102 of children with special educational needs attending special education schools) from February to April 2021. Participants completed the Perceived Stress Scale (PSS-10), the short form of the Profile of Mood States (POMS-S), and a demographic questionnaire. Our findings confirmed that parents of children attending special education schools reported higher levels of anxiety, reduced coping abilities, and poorer overall emotional well-being during the pandemic compared to parents of children attending regular schools. The type of educational setting that children attended was identified through multivariate analyses as the only factor consistently influencing all psychometric outcomes. Factors influencing anxiety levels included gender, older age, and family status, while family status and unemployment negatively impacted coping abilities. Taken together, the pandemic appears to have had a greater impact on the mental health of parents of children with special education needs compared to parents of children attending regular schools, highlighting the need for increased psychosocial support within this population group.
{"title":"[Comparative study of stress and psychological well-being in parents of children with and without special education needs during the COVID-19 pandemic].","authors":"Christina Boteli, Stavroula Bargiota, Anna Papakonstantinou, Agorastos Agorastos","doi":"10.22365/jpsych.2024.002","DOIUrl":"10.22365/jpsych.2024.002","url":null,"abstract":"<p><p>The COVID-19 pandemic, which rapidly spread worldwide in early 2020, has affected the daily lives of parents and their children in various ways. This study assessed the overall mental health status and stress experienced by parents during the COVID-19 pandemic and the differences between parents of children with special educational needs and parents of typically developing children. Additionally, we explored potential demographic factors that may influence these experiences. In this cross-sectional study, data were collected through questionnaires completed by a sample of 205 parents (103 of children with typical development attending regular mainstream schools and 102 of children with special educational needs attending special education schools) from February to April 2021. Participants completed the Perceived Stress Scale (PSS-10), the short form of the Profile of Mood States (POMS-S), and a demographic questionnaire. Our findings confirmed that parents of children attending special education schools reported higher levels of anxiety, reduced coping abilities, and poorer overall emotional well-being during the pandemic compared to parents of children attending regular schools. The type of educational setting that children attended was identified through multivariate analyses as the only factor consistently influencing all psychometric outcomes. Factors influencing anxiety levels included gender, older age, and family status, while family status and unemployment negatively impacted coping abilities. Taken together, the pandemic appears to have had a greater impact on the mental health of parents of children with special education needs compared to parents of children attending regular schools, highlighting the need for increased psychosocial support within this population group.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":"159-164"},"PeriodicalIF":0.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140028818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-02Epub Date: 2024-09-18DOI: 10.22365/jpsych.2024.012
Christos Ch Liapis
Cerebellum, along with it' s role in coordinating motor functions, exercises a significant regulatory influence in fields of cognitive and affective functions. Therefore, studying the effect of cerebrovascular atherosclerotic pathology on mood and cognition should not be limited to stenotic dysfunctions of carotid arteries, but also extend its methodological framework to the consideration of the integrity of vertebrobasilar system (VBS), cerebellar perfusion and posterior cerebral circulation in general, as it has not been yet sufficiently addressed whether VBS insufficiency is associated with deterioration of patients' mental and emotional status and quality of life (QoL). Vertebrobasilar circulatory dysfunction has been pointed out, since decades, as a cause of progressive memory impairment and dementia, due to multiple infarcts in cerebral areas which are topographically critical for mental and emotional functions. Indicative of the pathophysiological and anatomic-functional association of VBS with these neuro-psychiatric domains are cerebellar cognitive-affective syndrome (CCAS) and crossed cerebello-cerebral diaschisis (CCCD). Mental and psychiatric components of CCAS, along with ataxic motor disability, constitute the conceptual hypothesis of "dysmetry of thought", while diagnostic significance of mental dysfunctions and psychopathological manifestations, in terms of symptoms preceding motor impairments that ascribe cerebellar malfunction in the epicenter of their pathophysiology, such as cerebellar ataxias, in which, early recognition of CCAS may facilitate therapeutic interventions aimed at improving QoL, reveal that cerebellar pathology, either of degenerative etiology or vascular substrate on the ground of vertebrobasilar insufficiency (VBI) or other surgical conditions of the posterior fossa, is associated with deterioration of patients' QoL which is related to significant impairments in their cognitive functions with (co)manifested emotional disorders. Studies in animal models also support these conclusions. Since VBI is responsible for a wide range of psychiatric and neurological symptoms, new findings concurred with current indications advocating that, without consideration of VBS disorders, it is impossible to clarify the connection of cerebral perfusion dysfunctions to neurocognitive deficits. The inclusion of cerebellar perfusion disorders in scientific research and clinical approaches to cognitive and affective disorders that may occur in patients with cerebrovascular lesions constitutes a paradigm of best clinical practices implementation and interdisciplinary convergence of neurosciences and vascular medicine.
{"title":"[Cerebellar cognitive affective syndrome and vertebrobasilar ischemia. From cerebello-cerebral diaschisis to \"dysmetria of thought\"].","authors":"Christos Ch Liapis","doi":"10.22365/jpsych.2024.012","DOIUrl":"10.22365/jpsych.2024.012","url":null,"abstract":"<p><p>Cerebellum, along with it' s role in coordinating motor functions, exercises a significant regulatory influence in fields of cognitive and affective functions. Therefore, studying the effect of cerebrovascular atherosclerotic pathology on mood and cognition should not be limited to stenotic dysfunctions of carotid arteries, but also extend its methodological framework to the consideration of the integrity of vertebrobasilar system (VBS), cerebellar perfusion and posterior cerebral circulation in general, as it has not been yet sufficiently addressed whether VBS insufficiency is associated with deterioration of patients' mental and emotional status and quality of life (QoL). Vertebrobasilar circulatory dysfunction has been pointed out, since decades, as a cause of progressive memory impairment and dementia, due to multiple infarcts in cerebral areas which are topographically critical for mental and emotional functions. Indicative of the pathophysiological and anatomic-functional association of VBS with these neuro-psychiatric domains are cerebellar cognitive-affective syndrome (CCAS) and crossed cerebello-cerebral diaschisis (CCCD). Mental and psychiatric components of CCAS, along with ataxic motor disability, constitute the conceptual hypothesis of \"dysmetry of thought\", while diagnostic significance of mental dysfunctions and psychopathological manifestations, in terms of symptoms preceding motor impairments that ascribe cerebellar malfunction in the epicenter of their pathophysiology, such as cerebellar ataxias, in which, early recognition of CCAS may facilitate therapeutic interventions aimed at improving QoL, reveal that cerebellar pathology, either of degenerative etiology or vascular substrate on the ground of vertebrobasilar insufficiency (VBI) or other surgical conditions of the posterior fossa, is associated with deterioration of patients' QoL which is related to significant impairments in their cognitive functions with (co)manifested emotional disorders. Studies in animal models also support these conclusions. Since VBI is responsible for a wide range of psychiatric and neurological symptoms, new findings concurred with current indications advocating that, without consideration of VBS disorders, it is impossible to clarify the connection of cerebral perfusion dysfunctions to neurocognitive deficits. The inclusion of cerebellar perfusion disorders in scientific research and clinical approaches to cognitive and affective disorders that may occur in patients with cerebrovascular lesions constitutes a paradigm of best clinical practices implementation and interdisciplinary convergence of neurosciences and vascular medicine.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":"139-148"},"PeriodicalIF":0.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142352607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-02Epub Date: 2025-05-14DOI: 10.22365/jpsych.2025.009
Konstantinos N Fountoulakis, Konstantina Tsiggeni, Gregory Karakatsoulis
The aim of this study is to present the data from the psychiatric evaluation and treatment of passengers of the passenger train of the accident of Tempi in central Greece (28/2/2023) who were assessed and treated at the Trauma and Stress Disorders Unit of the Outpatient Clinic of the 3rd Department of Psychiatry, Aristotle University of Thessaloniki, at the University Hospital AHEPA. The material included two populations. The first was the total population of passengers on the passenger train (N=352). The second population was a subset of the first and consisted of those passengers who presented for diagnosis and follow-up (N=41). Frequency and percentage tables were generated, the Risk Ratio (RR) was calculated, and t-test and chi-square tests were used. Concerning the total of passengers on the train, it was estimated that 20-59 people would develop PTSD. The Trauma and Stress Disorders Unit of the 3rd Department of Psychiatry assessed and followed a total of 41 passengers, 18 males (43.90% aged 28.83±10.83 years) and 23 females (56.10% aged 32.87±14.16 years) with 34 (82.92%) of them developing PTSD, representing 2/3 of the expected PTSD cases after the accident. There was no significant effect of gender, physical injury or general psychiatric history on help-seeking, but there was an effect of proximity to the impact (wagon) and history of psychosis. The treatment included antidepressants (63.14%) and group psychotherapy (48.78%), with 58.54% showing significant improvement, and 7.32% deterioration. Males showed an overall increased likelihood of showing improvement (RR=1.53). Physical injury increased the likelihood of females not showing improvement (RR=2.44) while it did not affect men at all (RR=1.02). The findings of the present study are generally in agreement with the literature in terms of incidence and response to treatment, as well as concerning the role of gender, physical injury, and proximity to the event. An important finding was that males responded more to treatment and that physical injury adversely affected the outcome of females but not males, and this point should be considered as a novel contribution of the present study to the literature.
{"title":"[Post-traumatic stress disorder and outcome in train passengers of the Tempi accident in Greece: Data from the Trauma and Stress Disorders Unit of the 3rd Department of Psychiatry, A.U.Th., University Hospital AHEPA].","authors":"Konstantinos N Fountoulakis, Konstantina Tsiggeni, Gregory Karakatsoulis","doi":"10.22365/jpsych.2025.009","DOIUrl":"10.22365/jpsych.2025.009","url":null,"abstract":"<p><p>The aim of this study is to present the data from the psychiatric evaluation and treatment of passengers of the passenger train of the accident of Tempi in central Greece (28/2/2023) who were assessed and treated at the Trauma and Stress Disorders Unit of the Outpatient Clinic of the 3rd Department of Psychiatry, Aristotle University of Thessaloniki, at the University Hospital AHEPA. The material included two populations. The first was the total population of passengers on the passenger train (N=352). The second population was a subset of the first and consisted of those passengers who presented for diagnosis and follow-up (N=41). Frequency and percentage tables were generated, the Risk Ratio (RR) was calculated, and t-test and chi-square tests were used. Concerning the total of passengers on the train, it was estimated that 20-59 people would develop PTSD. The Trauma and Stress Disorders Unit of the 3rd Department of Psychiatry assessed and followed a total of 41 passengers, 18 males (43.90% aged 28.83±10.83 years) and 23 females (56.10% aged 32.87±14.16 years) with 34 (82.92%) of them developing PTSD, representing 2/3 of the expected PTSD cases after the accident. There was no significant effect of gender, physical injury or general psychiatric history on help-seeking, but there was an effect of proximity to the impact (wagon) and history of psychosis. The treatment included antidepressants (63.14%) and group psychotherapy (48.78%), with 58.54% showing significant improvement, and 7.32% deterioration. Males showed an overall increased likelihood of showing improvement (RR=1.53). Physical injury increased the likelihood of females not showing improvement (RR=2.44) while it did not affect men at all (RR=1.02). The findings of the present study are generally in agreement with the literature in terms of incidence and response to treatment, as well as concerning the role of gender, physical injury, and proximity to the event. An important finding was that males responded more to treatment and that physical injury adversely affected the outcome of females but not males, and this point should be considered as a novel contribution of the present study to the literature.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":" ","pages":"101-109"},"PeriodicalIF":0.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144120625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}